Haemacure CorporationMontreal, PQ Canada
Company Description
If you're having surgery, you want Haemacure to stick around. The company is developing sealants and adhesives to be used in procedures ranging from tonsillectomies to cardiovascular surgeries. The company's two leading candidates include a human tissue-based tissue glue called Hemaseel HMN and Hemaseel Thrombin intended to stop surface bleeding during surgery. Haemacure's sole marketed products are the HemaSyst and HemaMyst sealant delivery systems. Unable to secure financing, Haemacure filed for insolvency and is working with its creditors in Canada; the company's US subsidiary has filed Chapter 11 bankruptcy protection as well. Haemacure plans to sell its assets to partner
| 215 Redfern Ave., Ste. 100 | Phone: +1-514-282-3350 | http://www.haemacure.com |
| Montreal, PQ H3Z 3-L5 | Fax: +1-514-282-3358 | |
| Canada |
Haemacure Corporation Rankings
Executives
| 14 executives listed for Haemacure Corporation's Montreal, PQ location. | ||
| Chairman and CEO | Joseph Galli | |
|---|---|---|
| President and Director | Marc Paquin | |
| Director Finance and Administration | Lyne Paré | |
Financials
| Company Type | PublicHeadquarters |
|---|---|
| Fiscal Year-End | October |
| 2008 Employees | 20 |
Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Haemacure Corporation now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
